Treatment of Multiple Myeloma in Akita: Features and Outcomes in the Era of Novel Agents

Journal of clinical and experimental hematopathology : JCEH - Japan
doi 10.3960/jslrt.54.89
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

Japanese Society for Lymphoreticular Tissue Research

Related search

Cytogenetic Features and Clinical Outcomes of Patients With Non-Secretory Multiple Myeloma in the Era of Novel Agent Induction Therapy

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2020English

The Role of Allogeneic Transplantation for Multiple Myeloma in the Era of Novel Agents: A Study From the Japanese Society of Myeloma

Biology of Blood and Marrow Transplantation
TransplantationHematology
2018English

Multiple Myeloma: Future Directions in Autologous Transplantation and Novel Agents

Biology of Blood and Marrow Transplantation
TransplantationHematology
2013English

Kinase Inhibitors as Potential Agents in the Treatment of Multiple Myeloma

Oncotarget
Oncology
2016English

Front-Line Therapies for Elderly Patients With Transplant-Ineligible Multiple Myeloma and High-Risk Cytogenetics in the Era of Novel Agents

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2018English

Novel Drugs for the Treatment of Multiple Myeloma

Haematologica
Hematology
2010English

Treatment Patterns and Outcomes in Elderly Patients With Multiple Myeloma,

Blood
BiochemistryImmunologyCell BiologyHematology
2011English

Investigational Agents in Immunotherapy: A New Horizon for the Treatment of Multiple Myeloma

British Journal of Haematology
Hematology
2018English

Pcn113 - Evaluating the Economic Impact of Novel Agents for Treating Multiple Myeloma

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy